ARTICLE | Company News
Sangamo, Shire deal
February 6, 2012 8:00 AM UTC
Sangamo granted Shire exclusive, worldwide rights to zinc finger DNA-binding protein (ZFP) therapeutics targeting four genes - Factors VII, VIII, IX and X. Shire plans to develop the therapeutics for ...